Perkins Adelene Q 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Jan 7, 2019
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-01-04+243,000→ 243,000 totalExercise: $1.24Exp: 2029-01-04→ Common Stock (243,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.